These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 36768264)

  • 1. Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?
    Canyelles M; Borràs C; Rotllan N; Tondo M; Escolà-Gil JC; Blanco-Vaca F
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multi-omic Association Study of Trimethylamine N-Oxide.
    Manor O; Zubair N; Conomos MP; Xu X; Rohwer JE; Krafft CE; Lovejoy JC; Magis AT
    Cell Rep; 2018 Jul; 24(4):935-946. PubMed ID: 30044989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
    Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
    mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
    Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
    J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethylamine
    Naghipour S; Cox AJ; Peart JN; Du Toit EF; Headrick JP
    Nutr Res Rev; 2021 Jun; 34(1):125-146. PubMed ID: 32718365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimethylamine N-Oxide Generated by the Gut Microbiota: Potential Atherosclerosis Treatment Strategies.
    Zhu B; Ren H; Xie F; An Y; Wang Y; Tan Y
    Curr Pharm Des; 2022; 28(35):2914-2919. PubMed ID: 36121073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimethylamine N-oxide: A harmful, protective or diagnostic marker in lifestyle diseases?
    Nowiński A; Ufnal M
    Nutrition; 2018 Feb; 46():7-12. PubMed ID: 29290360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide.
    Zhu Y; Li Q; Jiang H
    APMIS; 2020 May; 128(5):353-366. PubMed ID: 32108960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis.
    Li D; Lu Y; Yuan S; Cai X; He Y; Chen J; Wu Q; He D; Fang A; Bo Y; Song P; Bogaert D; Tsilidis K; Larsson SC; Yu H; Zhu H; Theodoratou E; Zhu Y; Li X
    Am J Clin Nutr; 2022 Jul; 116(1):230-243. PubMed ID: 35348578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies.
    Heianza Y; Ma W; Manson JE; Rexrode KM; Qi L
    J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28663251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases.
    Zhen J; Zhou Z; He M; Han HX; Lv EH; Wen PB; Liu X; Wang YT; Cai XC; Tian JQ; Zhang MY; Xiao L; Kang XX
    Front Endocrinol (Lausanne); 2023; 14():1085041. PubMed ID: 36824355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimethylamine N-oxide in cardiovascular disease.
    Konieczny RA; Kuliczkowski W
    Adv Clin Exp Med; 2022 Aug; 31(8):913-925. PubMed ID: 35438848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.
    Schiattarella GG; Sannino A; Toscano E; Giugliano G; Gargiulo G; Franzone A; Trimarco B; Esposito G; Perrino C
    Eur Heart J; 2017 Oct; 38(39):2948-2956. PubMed ID: 29020409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
    Li XS; Obeid S; Klingenberg R; Gencer B; Mach F; Räber L; Windecker S; Rodondi N; Nanchen D; Muller O; Miranda MX; Matter CM; Wu Y; Li L; Wang Z; Alamri HS; Gogonea V; Chung YM; Tang WH; Hazen SL; Lüscher TF
    Eur Heart J; 2017 Mar; 38(11):814-824. PubMed ID: 28077467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis.
    Liu Y; Dai M
    Mediators Inflamm; 2020; 2020():4634172. PubMed ID: 32148438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota-associated trimethylamine N-oxide and increased cardiometabolic risk in adults: a systematic review and dose-response meta-analysis.
    Abbasalizad Farhangi M; Vajdi M
    Nutr Rev; 2021 Aug; 79(9):1022-1042. PubMed ID: 33270896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbial metabolite TMAO contributes to renal dysfunction in a mouse model of diet-induced obesity.
    Sun G; Yin Z; Liu N; Bian X; Yu R; Su X; Zhang B; Wang Y
    Biochem Biophys Res Commun; 2017 Nov; 493(2):964-970. PubMed ID: 28942145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimethylamine-N-oxide and 5-year mortality: the role of gut microbiota-generated metabolite from the CORE-Thailand cohort.
    Senthong V; Kiatchoosakun S; Wongvipaporn C; Phetcharaburanin J; Sritara P; Phrommintikul A;
    Sci Rep; 2024 Sep; 14(1):21264. PubMed ID: 39261513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota-derived trimethylamine N-oxide is associated with the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: a systematic review and dose-response meta-analysis.
    Li Y; Lu H; Guo J; Zhang M; Zheng H; Liu Y; Liu W
    Ann Med; 2023 Dec; 55(1):2215542. PubMed ID: 37246850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
    Winther SA; Øllgaard JC; Tofte N; Tarnow L; Wang Z; Ahluwalia TS; Jorsal A; Theilade S; Parving HH; Hansen TW; Hazen SL; Pedersen O; Rossing P
    Diabetes Care; 2019 Aug; 42(8):1512-1520. PubMed ID: 31123156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.